Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

73 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 28/06/2017 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, LASER ADMINISTRATION STUDY EYE
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 17)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 18) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 18)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 36) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 36)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 35) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 35)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 34) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 27/07/2017 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 34)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video